Loading...
01/10 16:12
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary indicates strong financial performance with organic sales growth, increased cash flow, and significant share repurchases. The Q&A section reveals optimism about brand performance, particularly TOUCHLAND, and strategic focus on M&A. Despite some uncertainties, such as future guidance and international challenges, the overall sentiment is positive, with strong brand momentum and innovation strategies. The positive aspects outweigh concerns, suggesting a likely positive stock price movement.
Organic Sales Growth 3.4% growth year-over-year, exceeding the outlook of 1%-2%. This growth was attributed to strong brand performance and innovation.
Adjusted Gross Margin Up 10 basis points year-over-year to 45.1%, exceeding the outlook. This increase was driven by productivity programs, higher-margin acquisitions, FX benefits, and a combination of volume, price, and mix, which offset inflation and tariff costs.
Adjusted EPS $0.81, up 2.5% year-over-year and $0.09 higher than the $0.72 outlook. This was driven by higher volume and favorable gross margin results.
U.S. Consumer Business Organic Sales Increased 2.3% year-over-year, with volume growth of 3.7% partially offset by a 1.4% price mix decline. Growth was led by THERABREATH mouthwash, ARM & HAMMER cat litter, and TROJAN condoms, while declines were seen in the vitamin business and WATERPIK water flossers.
ARM & HAMMER Liquid Laundry Detergent Consumption Grew 1.9% year-over-year, outperforming a flat category. Share reached 15%, and household penetration increased by 0.7 points to 30%.
ARM & HAMMER Litter Consumption Grew 5.3% year-over-year, slightly outperforming the category growth of 5%. This was achieved despite heightened competitive promotions.
THERABREATH Mouthwash Consumption Grew 17% year-over-year, while the overall mouthwash category declined. The brand's share reached 21.8%, with household penetration at 11% compared to the category's 65%.
HERO Acne Care Consumption Grew 5.2% year-over-year, outperforming a flat acne category. The brand maintained its #1 position with a 23.6% share, and household penetration was 9% compared to the category's 28%.
International Business Sales Growth Increased 8.4% year-over-year, with organic growth of 7.7%. This was driven by higher volume, price, and mix, with strong performance from HERO, THERABREATH, and BATISTE brands.
SPD Organic Sales Increased 4.2% year-over-year due to higher price, product mix, and volume.
Cash Flow from Operations Increased 19.6% year-over-year to $435.5 million, driven by strong operational performance.
Capital Expenditures $67.2 million for the first 9 months, a $58 million decrease year-over-year due to normalized capital spending.
Share Repurchases $300 million in Q3, bringing the year-to-date total to $600 million.
TOUCHLAND acquisition: TOUCHLAND is the fastest-growing brand in the U.S. hand sanitizer category, ranked #2 with household penetration under 7%. It experienced double-digit growth in Q3, exceeding expectations.
THERABREATH toothpaste launch: THERABREATH introduced a new toothpaste line targeting healthy gums, deep cleaning, and whitening. Retail launch is set for January 2026.
TROJAN G.O.A.T. launch: TROJAN launched a non-latex condom with Ultra Flex material for enhanced intimacy.
International sales growth: International business grew 8.4% in Q3, with organic growth of 7.7%, led by HERO, THERABREATH, and BATISTE brands.
Organic sales growth: Organic sales grew 3.4% in Q3, exceeding the 1%-2% outlook.
Gross margin improvement: Adjusted gross margin increased by 10 basis points, surpassing expectations.
Marketing investment: Marketing expenses increased to 12.8% of sales in Q3, with full-year marketing expected to exceed 11% of sales.
Vitamin business review: The company is reviewing its vitamin business, exploring supply chain streamlining, JV partnerships, and divestiture options, with a conclusion expected by the end of 2025.
Volatile macro environment: Conditions remain volatile with mixed consumer backdrop. High borrowing costs and delinquencies are weighing on discretionary spending, including big-ticket items like cars and housing.
Promotional intensity: Elevated promotional intensity in some categories could pressure margins and profitability.
Competitive pressures: Heightened competitive promotions, especially in the lightweight litter segment, could impact market share and pricing power.
Economic uncertainty: Economic uncertainty and inflationary pressures continue to pose risks to consumer spending and operational costs.
Vitamin business challenges: Declines in the vitamin business and ongoing strategic review, including potential divestitures, indicate underperformance and operational inefficiencies.
Inflation and tariff costs: 200 basis points of inflation and tariff costs negatively impacted gross margins.
Discontinued businesses: Discontinued product lines are expected to result in $30 million lower sales in Q4, creating a drag on revenue.
Full Year Organic Growth Outlook: The company expects full year organic growth of 1%, which is the midpoint of the prior range.
Adjusted EPS Growth for 2025: The company now expects full year adjusted EPS growth for 2025 to be $3.49, which is $0.02 higher than the previous outlook.
Marketing Investments: Marketing as a percentage of sales is expected to exceed 11%, with increased investments to continue momentum into 2026.
Pipeline of New Products: THERABREATH is introducing a new line of toothpaste with a retail launch set for January 2026. TROJAN launched a new non-latex condom, TROJAN G.O.A.T., designed to enhance intimacy.
International Sales Growth: The international business delivered sales growth of 8.4% in Q3, with organic growth of 7.7%. Growth was led by HERO, THERABREATH, and BATISTE brands.
Strategic Review of Vitamin Business: The company is undertaking a strategic review of its vitamin business, including streamlining the supply chain, exploring JV partnerships, and divestiture options. A conclusion is expected by the end of 2025.
Fourth Quarter Sales Growth: The company expects reported sales growth of approximately 3.5% and organic sales growth of approximately 1.5% in Q4.
Fourth Quarter Adjusted EPS: Adjusted EPS for Q4 is expected to be $0.83 per share, an increase of 8% versus last year's adjusted EPS.
Cash Flow from Operations: The outlook for cash flow from operations has been increased from $1.1 billion to $1.2 billion for 2025.
Share Repurchase Program: In the third quarter, the company repurchased an additional $300 million of shares, bringing the year-to-date share repurchases to $600 million for shareholders.
The earnings call summary indicates strong financial performance with organic sales growth, increased cash flow, and significant share repurchases. The Q&A section reveals optimism about brand performance, particularly TOUCHLAND, and strategic focus on M&A. Despite some uncertainties, such as future guidance and international challenges, the overall sentiment is positive, with strong brand momentum and innovation strategies. The positive aspects outweigh concerns, suggesting a likely positive stock price movement.
The earnings call highlights a cautious outlook with lowered revenue and EPS guidance, indicating potential struggles. Despite optimism in product innovation and international expansion, the focus on divestitures and tariff management suggests underlying challenges. The Q&A section reveals management's reluctance to provide specifics on strategic decisions and financial impacts, adding uncertainty. The combination of these factors, along with a reduced growth outlook, suggests a negative sentiment, likely leading to a stock price decline of -2% to -8% over the next two weeks.
The earnings call reveals several negative indicators: declining EPS and revenue, reduced organic sales, and decreased gross margins due to tariff and inflation pressures. The lack of share repurchase or dividend announcements and unclear management responses further add to the negative sentiment. Despite some positive aspects, like a stable promotional environment and international growth, the overall sentiment is negative due to weak financial performance and guidance.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
